UCGI 28 Panirinox: A randomized phase II study assessing Panitumumab plus FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | UCGI 28 Panirinox: A randomized phase II study assessing Panitumumab plus FOLFIRINOX or mFOLFOX6 in RAS and BRAF wild type metastatic colorectal cancer patients (mCRC) selected from circulating DNA analysis |
| Type de publication | Journal Article |
| Year of Publication | 2018 |
| Auteurs | Mazard T., Ghiringhelli F., Mollevi C., Assenat E., Gavoille C., Smith D., Pezzella V., Meddeb R., Pastor B., Ychou M., Thierry A.R |
| Journal | ANNALS OF ONCOLOGY |
| Volume | 29 |
| Date Published | OCT |
| Type of Article | Meeting Abstract |
| ISSN | 0923-7534 |